Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bernstein

Showing results (711-720 of 728) with videos related to

Pageof 73
Sort By:
Cancer|August 24, 2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrenceRichard A Larson, Eric L Sievers, Edward A Stadtmauer, et al.
Elife|February 26, 2015
Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signalingMichelle I Lin, Emily N Price, Sonja Boatman, et al.
Molecular Therapy. Methods & Clinical Development|September 24, 2025
Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heartElad Firnberg, Sigmund K S Tejada, Samantha A Yost, et al.
Blood|October 26, 2000
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasO W Press, J F Eary, T Gooley, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Blood|January 9, 2010
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.
Nature Communications|April 10, 2025
Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibitionMorgan E Walker, Wei Zhu, Janine H Peterson, et al.
Elife|May 30, 2020
Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adultsAlexandra N Trelle, Valerie A Carr, Scott A Guerin, et al.
Leukemia|April 9, 2010
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group studyP A Ho, T A Alonzo, K J Kopecky, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Pageof 73

Showing results (711-720 of 728) with videos related to

Sort By:
Pageof 73
Cancer|August 24, 2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrenceRichard A Larson, Eric L Sievers, Edward A Stadtmauer, et al.
Elife|February 26, 2015
Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signalingMichelle I Lin, Emily N Price, Sonja Boatman, et al.
Molecular Therapy. Methods & Clinical Development|September 24, 2025
Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heartElad Firnberg, Sigmund K S Tejada, Samantha A Yost, et al.
Blood|October 26, 2000
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasO W Press, J F Eary, T Gooley, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Blood|January 9, 2010
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.
Nature Communications|April 10, 2025
Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibitionMorgan E Walker, Wei Zhu, Janine H Peterson, et al.
Elife|May 30, 2020
Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adultsAlexandra N Trelle, Valerie A Carr, Scott A Guerin, et al.
Leukemia|April 9, 2010
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group studyP A Ho, T A Alonzo, K J Kopecky, et al.
Vaccine|July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial, R R Abu-Elyazeed, T Heineman, et al.
Pageof 73